DTX-P7, a peptide–drug conjugate, is highly effective for non-small cell lung cancer

Despite tremendous success of molecular targeted therapy together with immunotherapy, only a small subset of patients can benefit from them. Chemotherapy remains the mainstay treatment for most of tumors including non-small cell lung cancer (NSCLC); however, non-selective adverse effects on healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yao, Huang, Wei, Sun, Xiaojiao, Yang, Xiaozhou, Wu, Youming, Shi, Jiaojiao, Zheng, Ji, Fan, Shujie, Liu, Junya, Wang, Jun, Liang, Zhen, Yang, Nan, Liu, Zhenming, Liu, Yanyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164557/
https://www.ncbi.nlm.nih.gov/pubmed/35659720
http://dx.doi.org/10.1186/s13045-022-01274-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164557/
https://www.ncbi.nlm.nih.gov/pubmed/35659720
http://dx.doi.org/10.1186/s13045-022-01274-8

Ejemplares similares